AG˹ٷ

STOCK TITAN

Outset Medical to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Outset Medical (Nasdaq: OM), a medical technology company focused on revolutionizing dialysis technology, has scheduled its Q2 2025 financial results announcement for August 6, 2025 after market close.

The company will host a conference call at 2:00 PM PT (5:00 PM ET) on the same day, featuring Chair and CEO Leslie Trigg and CFO Renee Gaeta. Participants can register online to receive dial-in details, and a webcast will be available on the company's investor relations website.

Outset Medical (Nasdaq: OM), un'azienda di tecnologia medica dedicata a rivoluzionare la tecnologia della dialisi, ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per il 6 agosto 2025 dopo la chiusura del mercato.

La società terrà una conference call alle 14:00 PT (17:00 ET) dello stesso giorno, con la partecipazione del Presidente e CEO Leslie Trigg e del CFO Renee Gaeta. I partecipanti possono registrarsi online per ricevere i dettagli per la chiamata, e sarà disponibile una webcast sul sito web delle relazioni con gli investitori dell'azienda.

Outset Medical (Nasdaq: OM), una empresa de tecnología médica enfocada en revolucionar la tecnología de diálisis, ha programado el anuncio de sus resultados financieros del segundo trimestre de 2025 para el 6 de agosto de 2025 después del cierre del mercado.

La compañía realizará una llamada conferencia a las 2:00 PM PT (5:00 PM ET) ese mismo día, con la participación de la Presidenta y CEO Leslie Trigg y la CFO Renee Gaeta. Los participantes pueden registrarse en línea para recibir los detalles de la llamada, y habrá una transmisión en vivo disponible en el sitio web de relaciones con inversionistas de la empresa.

Outset Medical (나스�: OM)� 투석 기술 혁신� 주력하는 의료 기술 회사�, 2025� 2분기 재무 실적 발표2025� 8� 6� � 마감 후에 예정하고 있습니다.

회사� 같은 � 오후 2� PT (오후 5� ET)회장 � CEO Leslie TriggCFO Renee Gaeta가 참여하는 컨퍼런스 콜을 진행� 예정입니�. 참가자는 온라인으� 등록하여 전화 접속 정보� 받을 � 있으�, 회사 투자� 관� 웹사이트에서 웹캐스트� 제공됩니�.

Outset Medical (Nasdaq : OM), une entreprise de technologie médicale axée sur la révolution de la technologie de dialyse, a programmé l'annonce de ses résultats financiers du deuxième trimestre 2025 pour le 6 août 2025 après la clôture du marché.

L'entreprise organisera une conférence téléphonique à 14h00 PT (17h00 ET) le même jour, avec la participation de la présidente et PDG Leslie Trigg et de la directrice financière Renee Gaeta. Les participants peuvent s'inscrire en ligne pour recevoir les détails de connexion, et une webdiffusion sera disponible sur le site des relations investisseurs de l'entreprise.

Outset Medical (Nasdaq: OM), ein Medizintechnikunternehmen, das sich der Revolutionierung der Dialysetechnologie widmet, hat die Bekanntgabe der Finanzergebnisse für das zweite Quartal 2025 für den 6. August 2025 nach Börsenschluss geplant.

Das Unternehmen wird am selben Tag um 14:00 Uhr PT (17:00 Uhr ET) eine Telefonkonferenz mit Vorsitzender und CEO Leslie Trigg sowie CFO Renee Gaeta abhalten. Teilnehmer können sich online registrieren, um Einwahldaten zu erhalten, und ein Webcast wird auf der Investor-Relations-Webseite des Unternehmens verfügbar sein.

Positive
  • None.
Negative
  • None.

SAN JOSE, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset�), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the second quarter 2025 after the close of trading on Wednesday, August 6, 2025.

On the same day, at 2:00 p.m. Pacific time (5:00 p.m. Eastern time), Leslie Trigg, Chair and Chief Executive Officer, and Renee Gaeta, Chief Financial Officer, will host a conference call to discuss financial and operating results.

Conference Call Details
The conference call will begin at 2:00 p.m. Pacific time (5:00 p.m. Eastern time) on Wednesday, August 6, 2025. Those interested in joining the conference call may do so by . Once registered, participants will receive dial-in numbers and a unique pin to join the call. Participants are encouraged to register more than 15 minutes before the start of the call. A live and archived webcast of the event will be available on the “Investors� section of the Outset website at .

About Outset Medical, Inc.
Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo® Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

Contact
Jim Mazzola
Investor Relations


FAQ

When will Outset Medical (OM) report Q2 2025 earnings?

Outset Medical will report Q2 2025 earnings on Wednesday, August 6, 2025 after the market closes.

What time is Outset Medical's Q2 2025 earnings call?

The earnings conference call will begin at 2:00 PM Pacific Time (5:00 PM Eastern Time) on Wednesday, August 6, 2025.

Who will host Outset Medical's Q2 2025 earnings call?

The call will be hosted by Leslie Trigg (Chair and CEO) and Renee Gaeta (CFO).

How can I access Outset Medical's Q2 2025 earnings call?

Participants can register online to receive dial-in numbers and a unique pin. A live and archived webcast will be available on the Investors section of Outset Medical's website.
Outset Medical, Inc.

NASDAQ:OM

OM Rankings

OM Latest News

OM Latest SEC Filings

OM Stock Data

233.40M
16.45M
2.69%
87.93%
12.34%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
United States
SAN JOSE